Figure 71. N-Methyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide and Cardiovascular, Hematologic, and Metabolic Effects | Visualizations | ORD SEM PFAS 150 (2022)

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

100503400Figure 71. N-Methyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide and Cardiovascular, Hematologic, and Metabolic Effects

Note: Total bilirubin at 0.24 mg/kg-day was indicated as significant in the study. This is believed to be an error and is therefore not indicated as significant in the visual.